Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pepijn van Houten

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism|August 24, 2022
Differentiated thyroid carcinoma: An updatePepijn van Houten, Romana T Netea-Maier, Johannes W Smit
European Journal of Endocrinology|June 1, 2021
Persistent improvement of bone mineral density up to 20 years after treatment of Cushing's syndromePepijn van Houten, Romana Netea-Maier, Margreet Wagenmakers, et al.
Bone Reports|March 5, 2021
Spontaneous bone infarction of the distal femur in a patient with Cushing's disease: a case reportPepijn van Houten, Jacky de Rooy, Ingrid van der Geest, et al.
Journal of Clinical & Translational Endocrinology|May 13, 2026
Increased cytokine production capacity and persistent inflammation after achieving remission of Cushing's syndromePepijn van Houten, Annenienke C van de Ven, Antonius E van Herwaarden, et al.
Endocrine Connections|August 14, 2020
Venous thromboembolism in patients with adrenocortical carcinoma after surgeryJülide Durmuşoğlu, Henri J L M Timmers, Pepijn van Houten, et al.
Clinical and Translational Medicine|July 14, 2023
Concomitant systemic inflammation and cellular immunosuppression in patients with Cushing's syndromePepijn van Houten, Chunying Peng, Martin Jaeger, et al.
Cancer Immunology, Immunotherapy : CII|December 19, 2025
Immunomodulatory effects of lenvatinib in patients with advanced thyroid cancerPrashant Changoer, Chunying Peng, Pepijn van Houten, et al.
European Thyroid Journal|July 24, 2024
Digoxin treatment does not reinduce radioiodine uptake in radioiodine refractory non-medullary thyroid carcinomaPepijn van Houten, James Nagarajah, Janneke E W Walraven, et al.
European Thyroid Journal|June 8, 2026
Clinical actionability of molecular testing in advanced thyroid cancer: a real-world cohort studyPrashant Changoer, Pepijn van Houten, Daniele Ceruti, et al.
Endocrine Connections|March 24, 2025
High recovery rate of adrenal function after successful surgical treatment of Cushing's syndromeAnnenienke C van de Ven, Pepijn van Houten, Lisan Grevers, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Best Practice & Research. Clinical Endocrinology & Metabolism|August 24, 2022
Differentiated thyroid carcinoma: An updatePepijn van Houten, Romana T Netea-Maier, Johannes W Smit
European Journal of Endocrinology|June 1, 2021
Persistent improvement of bone mineral density up to 20 years after treatment of Cushing's syndromePepijn van Houten, Romana Netea-Maier, Margreet Wagenmakers, et al.
Bone Reports|March 5, 2021
Spontaneous bone infarction of the distal femur in a patient with Cushing's disease: a case reportPepijn van Houten, Jacky de Rooy, Ingrid van der Geest, et al.
Journal of Clinical & Translational Endocrinology|May 13, 2026
Increased cytokine production capacity and persistent inflammation after achieving remission of Cushing's syndromePepijn van Houten, Annenienke C van de Ven, Antonius E van Herwaarden, et al.
Endocrine Connections|August 14, 2020
Venous thromboembolism in patients with adrenocortical carcinoma after surgeryJülide Durmuşoğlu, Henri J L M Timmers, Pepijn van Houten, et al.
Clinical and Translational Medicine|July 14, 2023
Concomitant systemic inflammation and cellular immunosuppression in patients with Cushing's syndromePepijn van Houten, Chunying Peng, Martin Jaeger, et al.
Cancer Immunology, Immunotherapy : CII|December 19, 2025
Immunomodulatory effects of lenvatinib in patients with advanced thyroid cancerPrashant Changoer, Chunying Peng, Pepijn van Houten, et al.
European Thyroid Journal|July 24, 2024
Digoxin treatment does not reinduce radioiodine uptake in radioiodine refractory non-medullary thyroid carcinomaPepijn van Houten, James Nagarajah, Janneke E W Walraven, et al.
European Thyroid Journal|June 8, 2026
Clinical actionability of molecular testing in advanced thyroid cancer: a real-world cohort studyPrashant Changoer, Pepijn van Houten, Daniele Ceruti, et al.
Endocrine Connections|March 24, 2025
High recovery rate of adrenal function after successful surgical treatment of Cushing's syndromeAnnenienke C van de Ven, Pepijn van Houten, Lisan Grevers, et al.
Pageof 2